[{"address1": "Ugland House", "address2": "PO Box 309", "city": "Grand Cayman", "zip": "KY1-1104", "country": "Cayman Islands", "phone": "848 230 7430", "website": "https://www.adlainortye.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Adlai Nortye Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of cancer therapies in the United States and Mainland China. Its lead product is AN2025, a pan-phosphoinositide 3-kinase inhibitor, which is in Phase III clinical trial for the treatment of recurrent or metastatic head and neck squamous cell carcinomas. The company is also developing AN0025, a small molecule prostaglandin E receptor 4 antagonist to modulate the tumor microenvironment that is in a Phase Ib clinical trial for the treatment of recurrent non-small cell lung cancer and urothelial cancer after anti-PD-1/PD-L1 treatments, recurrent triple-negative breast cancer, microsatellite stable colorectal cancer, and cervical cancer after standard of care treatments; and AN4005, an oral small-molecule PD-L1 inhibitor, which is in Phase I clinical trial to induce and stabilize PD-L1 dimerization and thereby disrupt the interaction between PD-1 and PD-L1. Its preclinical candidates include AN8025, a multifunctional antibody as T cell and antigen-presenting cell modulator; AN1025, an oral small molecule degrader of \u00df-catenin; and AN9025, an oral small molecule pan-KRAS inhibitor. The company was founded in 2004 and is based in Grand Cayman, the Cayman Islands.", "fullTimeEmployees": 127, "companyOfficers": [{"maxAge": 1, "name": "Mr. Yang  Lu", "age": 44, "title": "CEO & Chairman", "yearBorn": 1980, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Kaiyang  Tang", "age": 59, "title": "President", "yearBorn": 1965, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Xiaofeng  Ye", "title": "Interim CFO and VP of Business Development & Commercialization Strategy", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Victoria Elizabeth Demby Ph.D.", "age": 53, "title": "Senior VP & Global Head of Regulatory Affairs", "yearBorn": 1971, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ngai Chiu  Tse M.D., Ph.D.", "age": 56, "title": "Head of Research & Development", "yearBorn": 1968, "exercisedValue": 0, "unexercisedValue": 0}], "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.91, "open": 1.8169, "dayLow": 1.71, "dayHigh": 1.865, "regularMarketPreviousClose": 1.91, "regularMarketOpen": 1.8169, "regularMarketDayLow": 1.71, "regularMarketDayHigh": 1.865, "payoutRatio": 0.0, "forwardPE": -1.0555556, "volume": 7189, "regularMarketVolume": 7189, "averageVolume": 5454, "averageVolume10days": 4730, "averageDailyVolume10Day": 4730, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 63099516, "fiftyTwoWeekLow": 1.69, "fiftyTwoWeekHigh": 15.55, "priceToSalesTrailing12Months": 12.619904, "fiftyDayAverage": 2.15016, "twoHundredDayAverage": 2.42294, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 130839376, "profitMargins": 0.0, "floatShares": 52398012, "sharesOutstanding": 31236900, "sharesShort": 6368, "sharesShortPriorMonth": 7218, "sharesShortPreviousMonthDate": 1740700800, "dateShortInterest": 1743379200, "sharesPercentSharesOut": 0.0002, "heldPercentInsiders": 0.06957, "heldPercentInstitutions": 0.00182, "shortRatio": 0.98, "shortPercentOfFloat": 0.0002, "impliedSharesOutstanding": 36900300, "bookValue": 1.446, "priceToBook": 1.1825726, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -54065000, "trailingEps": -6.18, "forwardEps": -1.62, "enterpriseToRevenue": 26.168, "enterpriseToEbitda": -2.058, "52WeekChange": -0.8814147, "SandP52WeekChange": 0.05430484, "quoteType": "EQUITY", "currentPrice": 1.71, "targetHighPrice": 9.0, "targetLowPrice": 9.0, "targetMeanPrice": 9.0, "targetMedianPrice": 9.0, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 97987000, "totalCashPerShare": 0.885, "ebitda": -63570000, "totalDebt": 39528000, "quickRatio": 1.804, "currentRatio": 1.846, "totalRevenue": 5000000, "debtToEquity": 74.064, "revenuePerShare": 0.215, "returnOnAssets": -0.4641, "grossProfits": 5000000, "freeCashflow": -48734876, "operatingCashflow": -66700000, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -12.9338, "financialCurrency": "USD", "symbol": "ANL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1695994200000, "regularMarketChangePercent": -10.4712, "regularMarketPrice": 1.71, "corporateActions": [], "postMarketTime": 1744933898, "regularMarketTime": 1744920000, "exchange": "NGM", "messageBoardId": "finmb_1830112145", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "shortName": "Adlai Nortye Ltd.", "longName": "Adlai Nortye Ltd.", "postMarketChangePercent": 0.0, "postMarketPrice": 1.71, "postMarketChange": 0.0, "regularMarketChange": -0.2, "regularMarketDayRange": "1.71 - 1.865", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 5454, "fiftyTwoWeekLowChange": 0.01999998, "fiftyTwoWeekLowChangePercent": 0.011834308, "fiftyTwoWeekRange": "1.69 - 15.55", "fiftyTwoWeekHighChange": -13.84, "fiftyTwoWeekHighChangePercent": -0.8900322, "fiftyTwoWeekChangePercent": -88.14147, "earningsTimestampStart": 1745325000, "earningsTimestampEnd": 1746189000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -6.18, "epsForward": -1.62, "epsCurrentYear": -0.88, "priceEpsCurrentYear": -1.9431819, "fiftyDayAverageChange": -0.44016004, "fiftyDayAverageChangePercent": -0.20471035, "twoHundredDayAverageChange": -0.71294, "twoHundredDayAverageChangePercent": -0.2942458, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2023-09-29", "cryptoTradeable": false, "displayName": "Adlai Nortye", "trailingPegRatio": null, "__fetch_time": "2025-04-19"}]